glp-1 effect on muscle mass Loss Explained Weighing the risk of GLP-1
Description
Several are now approved for weight loss, diabetes, sleep apnea, and reducing the risk of other complications
Jastreboff AM, Kaplan LM, Fras JP et al
Abbott NJ
Why Some Patients Experience Dizziness on Semaglutide Semaglutide slows gastric emptying and reduces appetite signaling in the brain, which can cause nausea, vomiting, and reduced fluid intake during the initial weeks of treatment
This involves your doctor submitting paperwork to justify the medical need for the drug before your insurer will approve coverage
Some of the early concern came from people I respected, including Peter Attia, who flagged lean-mass loss on scans in his own practice
